# Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non–Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pembrolizumab-plus-pemetrexed-and-platinum-in-nonsquamous-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marina Chiara Garassino,Shirish M. Gadgeel,Giovanna Speranza,Enriqueta Felip,Emilio Esteban,Manuel Dómine,Maximilian J. Hochmair,Steven Powell,Helge Bischoff,Nir Peled,Francesco Grossi,Ross Jennens,Martin Reck,Rina Hui,Edward B. Garon,Takayasu Kurata,Jhanelle E. Gray,Paul Schwarzenberger,Erin Jensen,M. Catherine Pietanza,Delvys Rodríguez‐Abreu |
| Citations | 684 |
| DOI | 10.1200/jco.22.01989 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.01989?role=tab |
| OpenAlex ID | https://openalex.org/W4321436832 |
| PMID | 36809080 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Marina Chiara Garassino](https://scholariq.org/researchers/marina-chiara-garassino/)
- [Jhanelle E. Gray](https://scholariq.org/researchers/jhanelle-e-gray/)
- [Edward B. Garon](https://scholariq.org/researchers/edward-b-garon/)
- [Enriqueta Felip](https://scholariq.org/researchers/enriqueta-felip/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.